1167 related articles for article (PubMed ID: 16619260)
1. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
2. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a putative cis-regulatory element that controls transcriptional activity of the pig uroplakin II gene promoter.
Kwon DN; Park MR; Park JY; Cho SG; Park C; Oh JW; Song H; Kim JH; Kim JH
Biochem Biophys Res Commun; 2011 Jul; 410(2):264-9. PubMed ID: 21658368
[TBL] [Abstract][Full Text] [Related]
4. [Effect of mouse uroplakin II promoter on human bladder cancer cell line].
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Xu CX; Huang GJ; Guo YL
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):22-5. PubMed ID: 15059347
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
6. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
7. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
Lichtenheld MG; Podack ER; Levy RB
J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890
[TBL] [Abstract][Full Text] [Related]
8. Cloning, sequencing, and expression analysis of the porcine uroplakin II gene.
Kwon DN; Seo HG; Kim JH
Biochem Biophys Res Commun; 2002 May; 293(2):862-9. PubMed ID: 12054551
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of the meprin beta gene in human cancer cells.
Matters GL; Bond JS
Mol Carcinog; 1999 Jul; 25(3):169-78. PubMed ID: 10411143
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene.
Running Deer J; Allison DS
Biotechnol Prog; 2004; 20(3):880-9. PubMed ID: 15176895
[TBL] [Abstract][Full Text] [Related]
11. Regulation of growth differentiation factor 9 expression in oocytes in vivo: a key role of the E-box.
Yan C; Elvin JA; Lin YN; Hadsell LA; Wang J; DeMayo FJ; Matzuk MM
Biol Reprod; 2006 Jun; 74(6):999-1006. PubMed ID: 16495478
[TBL] [Abstract][Full Text] [Related]
12. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
Yu YA; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
[TBL] [Abstract][Full Text] [Related]
13. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
14. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
Wang D; Wang Z; Tian J; He X; Chowdhury WH; Zhang X; Li S; Rodriguez R
Urol Oncol; 2010; 28(2):164-9. PubMed ID: 18440837
[TBL] [Abstract][Full Text] [Related]
15. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.
Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S
J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740
[TBL] [Abstract][Full Text] [Related]
16. Tissue- and bone cell-specific expression of bone sialoprotein is directed by a 9.0 kb promoter in transgenic mice.
Paz J; Wade K; Kiyoshima T; Sodek J; Tang J; Tu Q; Yamauchi M; Chen J
Matrix Biol; 2005 Aug; 24(5):341-52. PubMed ID: 15970437
[TBL] [Abstract][Full Text] [Related]
17. Tissue specific expression of human erythropoietin receptor in transgenic mice.
Liu ZY; Chin K; Noguchi CT
Dev Biol; 1994 Nov; 166(1):159-69. PubMed ID: 7958443
[TBL] [Abstract][Full Text] [Related]
18. A rat 8 kb dentin sialoprotein-phosphophoryn (DSP-PP) promoter directs spatial and temporal LacZ activity in mouse tissues.
Godovikova V; Li XR; Saunders TL; Ritchie HH
Dev Biol; 2006 Jan; 289(2):507-16. PubMed ID: 16310176
[TBL] [Abstract][Full Text] [Related]
19. Cloning and functional characterization of the 5' regulatory region of ovine Hormone Sensitive Lipase (HSL) gene.
Lampidonis AD; Stravopodis DJ; Voutsinas GE; Messini-Nikolaki N; Stefos GC; Margaritis LH; Argyrokastritis A; Bizelis I; Rogdakis E
Gene; 2008 Dec; 427(1-2):65-79. PubMed ID: 18824087
[TBL] [Abstract][Full Text] [Related]
20. Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
Zhang J; Ramesh N; Chen Y; Li Y; Dilley J; Working P; Yu DC
Cancer Res; 2002 Jul; 62(13):3743-50. PubMed ID: 12097284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
